Genedata Expands Biomarker Discovery Collaboration with Syngenta for Improving Metabolomic Data Processing
News Feb 26, 2009
Genedata has announced the extension of a biomarker discovery collaboration with Syngenta. Syngenta has added the Genedata Expressionist Refiner MS module for LC-MS and GC-MS metabolomic raw data processing and analysis to their existing Genedata Expressionist system.
Refiner MS expands Expressionist to process and analyze metabolomic raw MS data separately and in conjunction with microarray data, improving efficiency and enhancing the biomarker discovery process at Syngenta.
Syngenta has been successfully using the Genedata Expressionist Refiner Array and Analyst modules to process and analyze microarray data since 2005. With the rapid expansion of metabolomics research and the associated data volumes generated, Syngenta now uses Refiner MS to integrate MS data in their biomarker discovery projects.
With Refiner MS Syngenta can process rapidly and with full confidence in quality extremely large amounts of MS data directly from multiple hardware platforms via user defined, flexible workflows. Peaks selection is performed automatically in Refiner MS while statistical analysis and biological pathway mapping are done in the analytical module Analyst.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's DiseaseNews
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.READ MORE